{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:49:57Z","timestamp":1792684197601,"version":"4.5.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1093\/jac\/dky078","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T07:09:55Z","timestamp":1518678595000},"page":"1630-1638","source":"Crossref","is-referenced-by-count":8,"title":["Temocillin dosing in haemodialysis patients based on population pharmacokinetics of total and unbound concentrations and Monte Carlo simulations"],"prefix":"10.1093","volume":"73","author":[{"given":"Ana C","family":"Miranda Bastos","sequence":"first","affiliation":[{"name":"Pharmacologie cellulaire et mol\u00e9culaire, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain, Brussels, Belgium"},{"name":"Clinical Pharmacy Research Group, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan J","family":"Vandecasteele","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Spinewine","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Research Group, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7121-3623","authenticated-orcid":false,"given":"Paul M","family":"Tulkens","sequence":"additional","affiliation":[{"name":"Pharmacologie cellulaire et mol\u00e9culaire, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0052-7991","authenticated-orcid":false,"given":"Fran\u00e7oise","family":"Van Bambeke","sequence":"additional","affiliation":[{"name":"Pharmacologie cellulaire et mol\u00e9culaire, Louvain Drug Research Institute, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"key\n\t\t\t\t20180518035632_dky078-B1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1053\/j.ajkd.2010.04.016","article-title":"Infection-related hospitalizations in older patients with ESRD","volume":"56","author":"Dalrymple","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20180518035632_dky078-B2","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1681\/ASN.2013101082","article-title":"A patient-centered vision of care for ESRD: dialysis as a bridging treatment or as a final destination?","volume":"25","author":"Vandecasteele","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180518035632_dky078-B3","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/ndt\/gfv223","article-title":"Bacteraemia in haemodialysis patients\u2013not always Staphylococcus aureus","volume":"30","author":"Girndt","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180518035632_dky078-B4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/ndt\/gfv205","article-title":"Gram-negative bacteraemia in haemodialysis","volume":"30","author":"Murray","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180518035632_dky078-B5","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2215\/CJN.04651107","article-title":"Multidrug-resistant gram-negative bacteria among patients who require chronic hemodialysis","volume":"3","author":"Pop-Vicas","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180518035632_dky078-B6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dkn511","article-title":"Temocillin revived","volume":"63","author":"Livermore","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035632_dky078-B7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00003495-198500295-00023","article-title":"Effect of renal function and dialysis on temocillin pharmacokinetics","volume":"29","author":"Boelaert","year":"1985","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180518035632_dky078-B8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jac\/12.1.47","article-title":"Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function","volume":"12","author":"Leroy","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035632_dky078-B9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijantimicag.2015.09.005","article-title":"Thrice-weekly temocillin administered after each dialysis session is appropriate for the treatment of serious Gram-negative infections in haemodialysis patients","volume":"46","author":"Vandecasteele","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180518035632_dky078-B10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00228-009-0678-8","article-title":"Pharmacokinetics and dosage adjustment in patients with renal dysfunction","volume":"65","author":"Verbeeck","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20180518035632_dky078-B11"},{"key":"key\n\t\t\t\t20180518035632_dky078-B12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jac\/11.4.349","article-title":"The pharmacokinetics of temocillin in patients with normal and impaired renal function","volume":"11","author":"Boelaert","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035632_dky078-B13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00003495-198500295-00028","article-title":"Temocillin pharmacokinetics in normal and impaired renal function","volume":"29","author":"Hoffler","year":"1985","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180518035632_dky078-B14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of \u03b2-lactams, glycopeptides, and linezolid","volume":"17","author":"Craig","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"key\n\t\t\t\t20180518035632_dky078-B15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10096-007-0370-9","article-title":"In vitro activity of temocillin against prevalent extended-spectrum \u03b2-lactamases producing Enterobacteriaceae from Belgian intensive care units","volume":"26","author":"Glupczynski","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180518035632_dky078-B16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1179\/acb.2001.053","article-title":"Comparative in vitro activity of temocillin and other antimicrobial agents against Enterobacteriaceae isolated from patients admitted to five Belgian hospitals","volume":"56","author":"Vanhoof","year":"2001","journal-title":"Acta Clin Belg"},{"key":"key\n\t\t\t\t20180518035632_dky078-B17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-0-387-75613-4_3","volume-title":"Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics","author":"Mouton","year":"2014"},{"key":"key\n\t\t\t\t20180518035632_dky078-B18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpba.2013.12.002","article-title":"Development and validation of a high performance liquid chromatography assay for the determination of temocillin in serum of haemodialysis patients","volume":"90","author":"Miranda Bastos","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"key\n\t\t\t\t20180518035632_dky078-B19","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.clinbiochem.2015.02.006","article-title":"Validation of a HPLC-MS\/MS assay for the determination of total and unbound concentration of temocillin in human serum","volume":"48","author":"Ngougni Pokem","year":"2015","journal-title":"Clin Biochem"},{"key":"key\n\t\t\t\t20180518035632_dky078-B20","volume-title":"NONMEM Users Guides","author":"Beal","year":"2006"},{"key":"key\n\t\t\t\t20180518035632_dky078-B21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/CMR.00092-12","article-title":"Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents","volume":"26","author":"Gonzalez","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180518035632_dky078-B22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1365-2885.2002.00442.x","article-title":"Free drug fraction vs free drug concentration: a matter of frequent confusion","volume":"25","author":"Toutain","year":"2002","journal-title":"J Vet Pharmacol Ther"},{"key":"key\n\t\t\t\t20180518035632_dky078-B23","first-page":"387","article-title":"Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices","volume":"12","author":"Michaels","year":"1966","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"key\n\t\t\t\t20180518035632_dky078-B24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-199630050-00001","article-title":"A size standard for pharmacokinetics","volume":"30","author":"Holford","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20180518035632_dky078-B25","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.ejps.2017.05.056","article-title":"Allometric size: the scientific theory and extension to normal fat mass","volume":"109S","author":"Holford","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"key\n\t\t\t\t20180518035632_dky078-B26","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1208\/ps040427","article-title":"Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis","volume":"4","author":"Wahlby","year":"2002","journal-title":"AAPS PharmSci"},{"key":"key\n\t\t\t\t20180518035632_dky078-B27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10928-016-9487-8","article-title":"Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling","volume":"43","author":"Dosne","year":"2016","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"key\n\t\t\t\t20180518035632_dky078-B28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"Bergstrand","year":"2011","journal-title":"AAPS J"},{"key":"key\n\t\t\t\t20180518035632_dky078-B29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","article-title":"Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R","volume":"90","author":"Comets","year":"2008","journal-title":"Comput Methods Programs Biomed"},{"key":"key\n\t\t\t\t20180518035632_dky078-B30","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1007\/s11095-006-9067-5","article-title":"Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide","volume":"23","author":"Brendel","year":"2006","journal-title":"Pharm Res"},{"key":"key\n\t\t\t\t20180518035632_dky078-B31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jac\/dki079","article-title":"Standardization of pharmacokinetic\/pharmacodynamic (PK\/PD) terminology for anti-infective drugs: an update","volume":"55","author":"Mouton","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035632_dky078-B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180518035632_dky078-B33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/dkq388","article-title":"Trends in production of extended-spectrum \u03b2-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals","volume":"66","author":"Rodriguez-Villalobos","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035632_dky078-B34","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jac\/dkt383","article-title":"In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase","volume":"69","author":"Woodford","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035632_dky078-B35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/10.4.295","article-title":"Temocillin, in-vitro activity and the pharmacokinetics and tissue penetration in healthy volunteers","volume":"10","author":"Brown","year":"1982","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035632_dky078-B36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/jac\/dku465","article-title":"Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration","volume":"70","author":"Laterre","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035632_dky078-B37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2165\/00003495-198500295-00022","article-title":"Pharmacokinetics and tissue penetration of temocillin","volume":"29","author":"Lockley","year":"1985","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180518035632_dky078-B38","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1093\/jac\/dku226","article-title":"Unbound fraction of ertapenem in intensive care unit patients","volume":"69","author":"Liebchen","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035632_dky078-B39","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1517\/17425255.2010.506187","article-title":"Pharmacokinetic evaluation of piperacillin-tazobactam","volume":"6","author":"Hayashi","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key\n\t\t\t\t20180518035632_dky078-B40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jac\/dkm467","article-title":"Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection","volume":"61","author":"De Jongh","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035632_dky078-B41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/dkm179","article-title":"Temocillin susceptibility by BSAC methodology","volume":"60","author":"Andrews","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180518035632_dky078-B42","author":"EUCAST"},{"key":"key\n\t\t\t\t20180518035632_dky078-B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2017.06.002","article-title":"Antibacterial drug development program successes and failures: a pharmacometric explanation","volume":"36","author":"Ambrose","year":"2017","journal-title":"Curr Opin Pharmacol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/6\/1630\/24804856\/dky078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T21:03:52Z","timestamp":1570741432000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/6\/1630\/4951544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,3,22]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky078","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,3,22]]}}}